# A Double-Blind Pharmacokinetic Interaction Study Evaluating the Effect of a Single IV Infusion of GGF2 or Placebo on Midazolam Pharmacokinetics in Patients With Heart Failure

> **NCT01944683** · PHASE1 · COMPLETED · sponsor: **Acorda Therapeutics** · enrollment: 22 (actual)

## Conditions studied

- Heart Failure

## Interventions

- **OTHER:** Placebo
- **DRUG:** GGF2
- **DRUG:** Midazolam

## Key facts

- **NCT ID:** NCT01944683
- **Lead sponsor:** Acorda Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-09
- **Primary completion:** 2016-05
- **Final completion:** 2016-07
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2016-07-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01944683

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01944683, "A Double-Blind Pharmacokinetic Interaction Study Evaluating the Effect of a Single IV Infusion of GGF2 or Placebo on Midazolam Pharmacokinetics in Patients With Heart Failure". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01944683. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*